Regression of atherosclerosis

Area of Science:

• Cardiology
• Pharmacology
• Medical Imaging

Background:

• Atherosclerotic cardiovascular disease (CVD) is a major cause of premature death and hospitalization.
• Current treatments aim to reduce mortality and promote regression of atherosclerotic lesions.

Purpose of the Study:

• To review the latest advancements in CVD treatment and management.
• To highlight novel drugs targeting atherosclerosis.
• To discuss current and emerging imaging techniques for monitoring atherosclerosis progression.

Main Methods:

• Review of clinical trials focusing on hard end points (mortality, myocardial infarction).
• Analysis of trials using surrogate end points with imaging biomarkers.
• Examination of drug therapies targeting low-density lipoproteins, high-density lipoproteins, inflammation, and oxidation.

Main Results:

• Statins have demonstrated efficacy in promoting atherosclerosis regression.
• Several novel drug candidates targeting different pathways are under investigation.
• Imaging biomarkers offer rapid assessment of cardiovascular drug efficacy.

Conclusions:

• New therapeutic strategies and advanced imaging are crucial for managing atherosclerotic CVD.
• Personalized approaches combining novel drugs and precise imaging will improve atherosclerosis treatment.
• Continued research is essential to reduce the burden of cardiovascular disease.